Literature DB >> 30721936

Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission.

Ena Saini1, Mohammad Ali1, Ping Du1,2, Tonya Crook1, John Zurlo1.   

Abstract

We conducted a case-control study to examine the association between outpatient infectious disease (ID) follow-up and risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy. ID outpatient follow-up within 2 weeks was associated with lower risk of all-cause 30-day readmission (adjusted odds ratio, 0.33; P = .0001).
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  30-day readmission; infectious disease follow-up; outpatient parenteral antimicrobial therapy; OPAT

Mesh：

Substances：

Year:  2019        PMID： 30721936     DOI： 10.1093/cid/ciz073

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.

Authors:  Oyewole Chris Durojaiye; Augustinas Slucka; Evangelos I Kritsotakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-13       Impact factor: 3.267

2.  A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.

Authors:  Laura K Certain; Russell J Benefield; Michael Newman; Mingyuan Zhang; Frank O Thomas
Journal:  Open Forum Infect Dis       Date:  2022-04-15       Impact factor: 4.423

3.  The Impact of a Standardized Discharge Process on 30-Day Readmissions for Patients on Outpatient Parenteral Antibiotic Treatment.

Authors:  Charnicia E Huggins; Tae Eun Park; Eric Boateng; Cosmina Zeana
Journal:  Hosp Pharm       Date:  2020-12-29

4.  Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates.

Authors:  Thais Cristina Garbelini Salles; Santiago Grau Cerrato; Tatiana Fiscina Santana; Eduardo Alexandrino Medeiros
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

5.  The Voice of the Patient: Patient Roles in Antibiotic Management at the Hospital-to-Home Transition.

Authors:  Sima L Sharara; Alicia I Arbaje; Sara E Cosgrove; Ayse P Gurses; Kathryn Dzintars; Nicholas Ladikos; Sarojini Sonjia Qasba; Sara C Keller
Journal:  J Patient Saf       Date:  2022-04-01       Impact factor: 2.844

6.  Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Pranita Tamma; Alejandra Salinas; Deborah Williams; Sara E Cosgrove; Ayse P Gurses
Journal:  Open Forum Infect Dis       Date:  2020-05-21       Impact factor: 3.835

7.  Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?

Authors:  Sara C Keller; Nae-Yuh Wang; Alejandra Salinas; Deborah Williams; Jennifer Townsend; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2020-05-20       Impact factor: 3.835

8.  Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Monica V Mahoney; Lindsey M Childs-Kean; Parisa Khan; Christina G Rivera; Ryan W Stevens; Keenan L Ryan
Journal:  Curr Infect Dis Rep       Date:  2021-11-09       Impact factor: 3.725

Review 9.  Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit.

Authors:  Sara Ortonobes; Abel Mujal-Martínez; María de Castro Julve; Alba González-Sánchez; Rafael Jiménez-Pérez; Manuel Hernández-Ávila; Natalia De Alfonso; Ingrid Maye-Pérez; Teresa Valle-Delmás; Alba Rodríguez-Sánchez; Jessica Pino-García; Mònica Gómez-Valent
Journal:  Antibiotics (Basel)       Date:  2022-08-19

10.  Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines.

Authors:  Nicole Ng; Pamela Bailey; Rachel Pryor; Lillian Fung; Christine Veals; Kenneth Sabouri; Julie Reznicek
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.